NCT00189787View on ClinicalTrials.gov

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

Not specified

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Asthma, BronchialBronchial Asthma
Interventions
DRUG

tacrolimus

Trial Locations (49)

1125

Budapest

1431

Sofia

3390

Füzesabony

4400

Nyíregyháza

5800

Pleven

7000

Rousse

9010

Varna

9300

Csorna

9700

Szombathely

10365

Berlin

10717

Berlin

10969

Berlin

12203

Berlin

12687

Berlin

13357

Berlin

13597

Berlin

14050

Berlin

14469

Potsdam

15562

Rudersdorf

30159

Hanover

40217

Düsseldorf

42651

Solingen

49044

Dnipro

53119

Bonn

65187

Wiesbaden

80802

München

83003

Donetsk

94469

Deggendorf

107066

Moscow

143420

Moscow

194291

Saint Petersburg

194354

Saint Petersburg

197022

Saint Petersburg

197291

Saint Petersburg

214018

Smolensk

344015

Rostov-on-Don

620142

Yekaterinburg

656 91

Brno

257 42

Krhanice

775 20

Olomouc

787 52

Šumperk

15-025

Bialystok

31-133

Krakow

90-153

Lodz

91-520

Lodz

20-718

Lublin

33-100

Tarnów

50-434

Wroclaw

03680

Kiev

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Europe B.V.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00189787 - Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma | Biotech Hunter | Biotech Hunter